Background. Real world evidence is important for informing healthcare practice and developing medical products and has gained broad interest in healthcare. Compound Kushen Injection (CKI) has been widely applied into treatment of colon carcinoma (CC) in China. Postapproval drug assessment related retrospective studies using electrical medical record (EMR) collected from hospital information system (HIS) is one of the most important categories of real-world study (RWS). Based on HIS EMR, interrelationships of combined medication of CKI in treating CC can be validated in real world settings. Methods. This study was conducted based on a large-scale integrated database of EMR derived from HIS. EMR of 3328 patients initially diagnosed with CC among 49,597 patients treated with CKI were included in the study. Descriptive statistical analyses and apriori algorithm based association rule analyses were performed, respectively, to validate frequency distribution and interrelationships of combined medication of CKI in treating CC. Results. The pharmacological mechanisms of TCMs that have been commonly used in conjunction with CKI include heatclearing and detoxifying, qi-reinforcing, blood circulation-promoting and stasis-removing, blood-stanching, and qi-regulating. For modern medicines, antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids are most often combined with CKI. The association rules of medication combinations of CKI in treating CC in real world manifest certain laws for both TCMs and modern medicines. They are generally in line with CC treatment guidelines. Conclusions. It is a common practice for CKI to be integrated with both modern medicines and TCMs when treating CC in China. The associations of medication combinations of CKI in treating CC manifest certain laws for both TCMs and modern medicines. The RWS for validating interrelationships of combined medication may provide evidence for rational use of CKI. Further explorations are needed to verify and expand the conclusions.
2
Evidence-Based Complementary and Alternative Medicine been widely applied into treatment of various kinds of malignant tumors in China, including colon carcinoma (CC) [3] . CKI has been listed in the Drug Directory for National Medical Insurance, Employment Injury Insurance, and Maternity Insurance [4] . It is also listed as therapeutic medication for CC according to Guideline for Diagnosis and Treatment of Tumor in TCM [5] published by China Association of Chinese Medicine in 2008 and Clinical Practice Guidelines of Chinese Medicine in Oncology [6] issued by China Academy of Chinese Medical Sciences in 2014.
Trails have showed that CKI can improve overall efficiency of the treatment for multiple malignant tumors, relieve clinical symptoms such as cancer pain, fever, and fatigue, and potentiate the efficacy of chemotherapy and radiotherapy for CC with additional toxicity reduction effect [3, 7, 8] . The mechanisms of CKI comprise inhibiting the proliferation and metastasis of tumor cells [9] [10] [11] , inducing the differentiation and apoptosis of tumor cells [12, 13] , restraining the formation of tumor neovascularization [14] , suppressing tumors' drug resistance [15] , and inducing the autophagy of tumor cells [16, 17] . Previous studies show that compared with pure chemotherapy treatment, CKI combined with chemotherapy can improve clinical effects and patients' life quality, extend lifetime, and reduce the toxicity of chemotherapy [18] [19] [20] . The mechanism of which includes improving the immunity of patients with CC [21] , restraining the proliferation of colon cancer cells and inducing their apoptosis [22, 23] , suppressing the formation of tumor neovascularization [24] , and curbing the activation of NF-B inside macrophage [25] .
Real-world studies (RWS) include a spectrum of studies that apply various methods to data collected from real world settings [26] . Real world evidence is important for informing healthcare practice and developing medical products and has gained broad interest in healthcare [27] . In China, the term "real world evidence" was not explicitly used until 2010, when researchers from our group in Institute of Basic Research in Clinical Medicine (IBRCM), China Academy of Traditional Chinese Medical Sciences (CACMS), carried out the first RWS to evaluate traditional Chinese medicine interventions [28] . Retrospective studies using electrical medical record (EMR) collected from hospital information system (HIS) are one of the most important categories of RWS [27] and are important for postapproval drug assessment [29] , healthcare quality improvement [30] , and new indications of medical products [31] .
EMR stored in HIS have inherent strengths of high reliability of sources, large scale of samples, accuracy of recording, reasonable framework, and abundance in dimensions. Particularly, it records detailed medication orders throughout the whole treatment process at the time of hospitalization [32] . The laws of combined medication can thus be found through the large quantity of data provided by HIS. Considering CKI has been widely applied into treatment of CC in China, our present study aimed to validate the interrelationships of combined medication of CKI in the treatment of CC by using HIS EMR and thus provide evidence for rational use of CKI in real world settings.
Methods

Data Sources.
This study was conducted based on a large-scale integrated data warehouse of EMR from HIS of 39 Class A tertiary hospitals in China, that was built by IBRCM of CACMS [26, 33, 34] . EMR of patients whose firstlisted diagnoses were CC and were treated with CKI were extracted from 22 hospitals among the above-mentioned medical centers.
Standardization of Database
Structure. Due to the difference in data structure of HIS of varied hospitals, IBRCM, by standardizing original data structure, built an integrated database with the same structure of variables that contained general information, diagnosis information, medication orders, and laboratory test results. Patient's ID is the only index that links different data subsets.
Data Standardization.
All analyses were made on account of standardized modern medicine diagnosis information and medication orders. Disease names were standardized with reference to ICD-10 [35] . Chinese patent medicines with the same ingredients but in different drug forms were standardized and merged, while their TCM theory based pharmacological mechanisms were classified in accordance with their major functions. Modern medicines were standardized by translating their trade name into chemical name (if applicable), and their pharmacological effects were normalized and categorized with reference to Pharmacopoeia of the People's Republic of China (2010) [36] .
Exclusion Criteria.
Exclusion criteria of combined medicines are as follows: (1) solvents, including glucose injection, sodium chloride injection, and glucose and sodium chloride injection, were excluded; (2) potassium chloride and vitamins (except for Vitamin C) were excluded; (3) insulin when combined with glucose injection or glucose and sodium chloride injection was excluded; (4) heparin only when administrated through intravenous drip, intravenous injection, pumping, or subcutaneous injection was excluded; (5) combined drugs the medication administration time of which did not fall into that of CKI were excluded. 
Results
Characteristics of General Information. EMR of 3328
patients first diagnosed with CC among 49597 patients who were treated with CKI at the time of hospitalization were included in the study. The earliest record of case was August 2002, while the latest one was December 2014. The 
Distribution Characteristics of Combined TCMs. 227
traditional Chinese medicines were used in conjunction with CKI. Top 20 were tabulated based on the frequency of use (Table 1) .
Distribution Characteristics of Combined Modern
Medicines. 760 modern medicines were used in conjunction with CKI. Top 20 were tabulated based on the frequency of use (Table 2) .
TCM Pharmacological Mechanism Distribution Characteristics of Combined TCMs.
Frequency order of pharmacological mechanism of combined TCMs (top 20) is shown in Table 3 . Table 5 . The features are visually presented based on network of associations in Figure 1 .
In Figure 1 , in order to show the difference of correlation between combined drugs, use frequency≧1.06% is represented by bold line; use frequency≦0.5% is represented by dotted line; use frequency between 0.5% and 1.06% is represented by fine line.
ARA of Combined Modern Medicines and Merged Analysis.
Modern medicines are used in conjunction with CKI. The association rules between different medicines obtained by ARA are ordered by Support. Top 10 are listed in Table 6 . The features are visually presented based on network of associations in Figure 2 . In merged analysis, the network of associations is shown in Figure 3 .
In Figure 2 , use frequency≧20.3% is represented by bold line; use frequency≦12% is represented by dotted line; use frequency between 12% and 20.3% is represented by fine line.
In Figure 3 , use frequency≧7.49% is represented by bold line; use frequency≦2.87% is represented by dotted line; use frequency between 2.87% and 7.49% is represented by fine line. 
ARA of Pharmacological Mechanisms of Combined TCMs.
The association rules between different pharmacological mechanisms of combined TCMs obtained by ARA are ordered by Support. Top 10 are listed in Table 7 . The features are visually presented based on network of associations in Figure 4 .
Evidence G a n m a o Q i n g r e g r a n u l e s = G a n m a o Q i n g r e g r a n u l e s = >Yadanzi Youru injection 1.292 14.6 8 Simotang oral liquid =>Ganmao Qingre granules 1.262 19.6 9 G a n m a o Q i n g r e g r a n u l e s = >Simotang oral liquid In Figure 4 , in order to show the difference of correlation of pharmacological mechanism between combined drugs, use frequency≧2.08% is represented by bold line; use frequency≦0.42% is represented by dotted line; use frequency between 0.42% and 2.08% is represented by fine line.
ARA of Pharmacological Mechanism of Combined Modern
Medicines, and Merged Analysis. Modern medicines are used in conjunction with CKI. The association rules between different pharmacological mechanisms of combined modern medicines obtained by ARA are ordered by Support. Top 10 are listed in Table 8 . The features are visually presented based on network of associations in Figure 5 . In merged analysis, the network of associations is shown in Figure 6 .
In Figure 5 , use frequency≧30.4% is represented by bold line; use frequency≦17.4% is represented by dotted line; use frequency between 17.4% and 30.4% is represented by fine line.
In Figure 6 , use frequency≧28.1% is represented by bold line; use frequency≦5.15% is represented by dotted line; use frequency between 5.15% and 28.1% is represented by fine line.
Discussion
ARA is widely used to analyze internal connections hidden in item sets of multidimensional data [37] [38] [39] . In this study, ARA is performed to generate candidate item sets under a threshold control of support and confidence and finally identify association rules that highlight general trends in the database of combined TCMs and modern medicines. Association rules are presented in the implicative expression (2) heat-clearing and detoxifying; (3) blood circulation-promoting and stasis-removing; (4) spleen-invigorating and stomach-harmonizing; (5) Qi-regulating; (6) bowel-relaxing; (7) blood-regulating; (8) Blood stasis-removing; (9) blood-stanching; (10) swelling-reducing and mass-resolving. of A => B. Support (A -> B) = P (A U B). Support equals the probability of coadministration of drugs A and B. It is used to assess the frequency and importance of association rules. Confidence (A -> B) = P (A | B). Confidence equals the probability of administration of drug B after drug A is used. It is capable of assessing the intensity and reliability of association rules [40] .
In terms of features of combination with other TCMs, CKI is most often administrated in conjunction with TCMs with the pharmacological mechanisms of qi-reinforcing, heat-clearing and detoxifying, blood circulation-promoting Heat-clearing and detoxifying =>Blood-stanching 5.32 11.5 7 blood circulation-promoting and stasis-removing=>Qi-reinforcing 5.02 53.5 8
Qi-reinforcing =>Blood circulation-promoting and stasis-removing 5.02 14.4 9 Q i -r e g u l a t i n g = >Heat-clearing and detoxifying 4.78 58. 2 10 Heat-clearing and detoxifying =>Qi-regulating 4.78 10.4 and stasis-removing, spleen-invigorating and stomachharmonizing, and qi-regulating. The common combinations include the following: (1) on the basis of combination of CKI and qi-reinforcing, using one of the following:
heat-clearing and detoxifying, blood circulation-promoting and stasis-removing, blood-stanching, bowel-relaxing, qiregulating, spleen-invigorating and stomach-harmonizing, and blood-regulating; (2) on the basis of combination of CKI and heat-clearing and detoxifying, using one of the following: blood circulation-promoting and stasis-removing, blood-stanching, bowel-relaxing, qi-regulating, spleeninvigorating and stomach-harmonizing, blood-regulating, swelling-reducing and mass-resolving, for yin-tonifying, for reviving yang to save from collapse, qi-reinforcing and blood-nourishing; (3) on the basis of combination of CKI and blood circulation-promoting and stasis-removing, using blood-stanching and qi-regulating; (4) on the basis of combination of CKI and qi-regulating, using bowel-relaxing used. In TCM theory, a number of pathogenic factors cause the malfunction of large intestine and stagnant movement of qi, blood, and body fluid, leading to certain pathological changes such as stagnation of qi and blood, phlegm stasis, damp turbidity, and heat-toxicity. Stagnated in large intestine, these pathological products interact with each other and eventually form tangible lumps as time goes by. The above combinations of TCMs when treating CC have effects of reinforcing healthy qi, clearing heat and detoxication, reinforcing qi and invigorating spleen, eliminating dampness and regulating the stomach, regulating qi and relieving pain, smoothing qi, and removing stasis. In terms of features of combination with modern medicines, CKI is most often administrated in conjunction with antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids. The common combinations include the following: (1) on the basis of combination of CKI and antineoplastic chemotherapeutic drugs, using one of the following drugs: immunomodulator, 5-HT receptor antagonist drugs, antibiotics, antifolate, nutritious drugs, corticosteroids, hepatic protector, proton pump inhibitor, dopamine receptor antagonist; (2) on the basis of combination of CKI and immunomodulator, using one of the following drugs: 5-HT receptor antagonist drugs, antibiotics, nutritious drugs, hepatic protector, proton pump inhibitor; (3) on the basis of combination of CKI and antibiotics, using nutritious drugs; (4) on the basis of combination of CKI and corticosteroids, using antifolate, dopamine receptor antagonist, and antineoplastic drugs; (5) CKI being administrated in conjunction with antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids. According to guidelines [41] [42] [43] , major therapeutic strategy to treat CC includes chemotherapy before operation and administration of antibiotics, immunomodulator, and corticosteroids after operation. Antineoplastic chemotherapeutic drugs, antibiotics, and immunomodulator are strongly recommended with a view to raising total survival rate, preventing postoperative infection, prolonging survival period for recurrent patients, and improving life quality. The above combinations have effects of inhibiting the proliferation of CC cells, preventing infection, alleviating the side effect of radiotherapy and chemotherapy, and mitigating local compression and edema. They are confronted with clinical guidelines for diagnosis and treatment of CC [42, 44, 45] .
In merged analysis, the common combinations include the following: (1) on the basis of combination of CKI and heatclearing and detoxifying, antineoplastic chemotherapeutic drugs and immunomodulator are used at the same time; (2) on the basis of combination of CKI and qi-reinforcing, antineoplastic chemotherapeutic drugs are used; (3) on the basis of combination of CKI and antibiotics, antineoplastic chemotherapeutic drugs, and immunomodulator are used at the same time; (4) on the basis of combination of CKI and antineoplastic chemotherapeutic drugs, 5-HT receptor antagonist drugs, and corticosteroids are used, respectively; (5) on the basis of combination of CKI and 5-HT receptor antagonist drugs, corticosteroids are used; (6) on the basis of combination of CKI and immunomodulator, either antineoplastic chemotherapeutic drugs, 5-HT receptor antagonist drugs, or corticosteroids is added. The combination of TCM and chemotherapeutics has been proved to have the effect of relieving symptoms, raising life quality, strengthening immune functions, and alleviating the side effect of chemotherapy when treating CC [18, 46, 47] .
Strengths of our present study should be noted.
(1) The data source of this study is of high quality. The large-scale integrated data warehouse records EMR of over three million cases from HIS of 39 Class A tertiary hospitals nationwide in China. It covers demographic data, diagnosis information of TCM and modern medicine, medication orders, common clinical test results, and treatment outcomes [33, 34] . (2) Standardization of database structure, standardization of different categories of variables, and strict logic checking were performed before analysis to ensure quality control. (3) The advantages of ARA include good adaptability for analysis of multidimensional and nonlinear medication and disease related variables [48] .
Disadvantages of this study should also be addressed. (1) HIS EMR is derived from real-world records in the process of clinical treatment and is not originally designed for research purposes. (2) Selection bias may exist because data were derived from participants in 22 hospitals in China, and therefore the cases are likely not representative of patients in other medical centers nationwide. (3) Apriori algorithm generates a large quantity of candidate sets in the ARA procedure by repeatedly scanning all the records in database. Hence, such large amount of calculation by apriori algorithm may consume too many resources when it comes to the analysis of large-scale database.
Conclusion
CKI has been used extensively integrated with both modern medicines and TCMs when treating CC in China. The pharmacological mechanisms of TCMs that most frequently combined with CKI include heat-clearing and detoxifying, qi-reinforcing, blood circulation-promoting and stasisremoving, blood-stanching, and qi-regulating. For modern medicines, antibiotics, antineoplastic chemotherapeutic drugs, immunomodulator, 5-HT receptor antagonist drugs, and corticosteroids are most often combined with CKI. The associations of medication combinations of CKI in treating CC in real world manifest certain laws for both TCMs and modern medicines. Further explorations are needed to verify and expand the conclusions.
